| Medical and Health Sciences | Lifetime | 832 | US 426 | 99.96 |
| Epidemiology | Lifetime | 119 | US 63 | 99.83 |
| Clinical Neurology | Lifetime | 53 | US 22 | 99.80 |
| Pulmonary and Respiratory Medicine | Lifetime | 178 | US 93 | 99.78 |
| Cardiology and Cardiovascular Medicine | Lifetime | 881 | US 459 | 97.99 |
| Internal Medicine | Lifetime | 230 | US 95 | 94.83 |
| Rehabilitation | Lifetime | 491 | US 192 | 93.01 |
| Emergency Medicine | Lifetime | 978 | US 517 | 87.26 |
| Clinical Neurology | 2021-2025 | 43 | US 13 | 99.14 |
| Epidemiology | 2021-2025 | 153 | US 46 | 99.01 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 444 | US 145 | 95.26 |
| Internal Medicine | 2021-2025 | 122 | US 43 | 80.97 |
| Intracranial Aneurysms: Treatment and Complications | Lifetime | 13 | US 11 | 99.82 |
| Neurosurgical Procedures and Complications | Lifetime | 6 | US 3 | 99.86 |
| Intracerebral and Subarachnoid Hemorrhage Research | Lifetime | 10 | US 6 | 99.77 |
| Acute Ischemic Stroke Management | Lifetime | 35 | US 13 | 99.81 |
| Cerebrovascular and Carotid Artery Diseases | Lifetime | 39 | US 18 | 99.81 |
| Traumatic Brain Injury and Neurovascular Disturbances | Lifetime | 46 | US 26 | 99.78 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 170 | US 68 | 99.46 |
| Stroke Rehabilitation and Recovery | Lifetime | 121 | US 44 | 99.33 |
| Long-Term Effects of COVID-19 | Lifetime | 155 | US 40 | 98.42 |
| Cardiovascular Health and Disease Prevention | Lifetime | 169 | US 81 | 99.03 |
| Vascular Malformations Diagnosis and Treatment | Lifetime | 130 | US 90 | 98.89 |
| Neurological Complications and Syndromes | Lifetime | 80 | US 42 | 98.22 |
| Cerebral Venous Sinus Thrombosis | Lifetime | 140 | US 69 | 97.99 |
| COVID-19 Clinical Research Studies | Lifetime | 783 | US 184 | 97.28 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 599 | US 220 | 97.37 |
| Cerebrospinal fluid and hydrocephalus | Lifetime | 524 | US 250 | 96.40 |
| Moyamoya disease diagnosis and treatment | Lifetime | 181 | US 73 | 96.24 |
| COVID-19 and healthcare impacts | Lifetime | 833 | US 300 | 92.56 |
| Renal and Vascular Pathologies | Lifetime | 988 | US 501 | 95.14 |
| Spinal Hematomas and Complications | Lifetime | 211 | US 123 | 93.88 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 769 | US 238 | 93.42 |
| Cardiovascular Health and Risk Factors | Lifetime | 555 | US 308 | 93.57 |
| Myasthenia Gravis and Thymoma | Lifetime | 710 | US 230 | 92.73 |
| Aortic Thrombus and Embolism | Lifetime | 127 | US 61 | 89.73 |
| Trigeminal Neuralgia and Treatments | Lifetime | 748 | US 252 | 89.19 |
| Oropharyngeal Anatomy and Pathologies | Lifetime | 469 | US 120 | 80.14 |
| Intracerebral and Subarachnoid Hemorrhage Research | 2021-2025 | 24 | US 8 | 98.74 |
| Stroke Rehabilitation and Recovery | 2021-2025 | 68 | US 17 | 98.35 |
| Acute Ischemic Stroke Management | 2021-2025 | 108 | US 33 | 99.02 |
| Neurosurgical Procedures and Complications | 2021-2025 | 41 | US 18 | 97.53 |
| Cerebrovascular and Carotid Artery Diseases | 2021-2025 | 170 | US 62 | 97.77 |
| Long-Term Effects of COVID-19 | 2021-2025 | 544 | US 124 | 95.25 |
| Venous Thromboembolism Diagnosis and Management | 2021-2025 | 398 | US 127 | 95.73 |
| Intracranial Aneurysms: Treatment and Complications | 2021-2025 | 232 | US 106 | 95.23 |
| Traumatic Brain Injury and Neurovascular Disturbances | 2021-2025 | 383 | US 146 | 94.86 |
| Peripheral Artery Disease Management | 2021-2025 | 933 | US 378 | 82.82 |
| Trigeminal Neuralgia and Treatments | 2021-2025 | 435 | US 101 | 75.08 |
| Neurological Complications and Syndromes | 2021-2025 | 395 | US 94 | 67.30 |
